Replacement therapy for bleeding episodes in factor VII deficiency
- 1 January 2013
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 109 (02) , 238-247
Abstract
Patients with inherited factor VII (FVII) deficiency display different clinical phenotypes requiring ad hoc management. This study evaluated treatments for spontaneous and traumatic bleeding using data from the Seven Treatment Evaluation Registry (STER). One-hundred one bleeds were analysed in 75 patients (41 females; FVII coagulant activity <1–20%). Bleeds were grouped as haemarthroses (n=30), muscle/subcutaneous haematomas (n=16), epistaxis (n=12), gum bleeding (n=13), menorrhagia (n=16), central nervous system (CNS; n=9), gastrointestinal (GI; n=2) and other (n=3). Of 93 evaluable episodes, 76 were treated with recombinant, activated FVII (rFVIIa), eight with fresh frozen plasma (FFP), seven with plasma-derived FVII (pdFVII) and two with prothrombin-complex concentrates. One-day replacement therapy resulted in very favourable outcomes in haemarthroses, and was successful in muscle/subcutaneous haematomas, epistaxis and gum bleeding. For menorrhagia, single- or multiple-dose schedules led to favourable outcomes. No thrombosis occurred; two inhibitors were detected in two repeatedly treated patients (one postrFVIIa, one post-pdFVII). In FVII deficiency, most bleeds were successfully treated with single ‘intermediate’ doses (median 60 µg/kg) of rFVIIa. For the most severe bleeds (CNS, GI) short- or long-term prophylaxis may be optimal.Keywords
Funding Information
- University of L’Aquila
This publication has 15 references indexed in Scilit:
- Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STERBritish Journal of Haematology, 2010
- Bleeding disorders in the tribe: result of consanguineous in breedingOrphanet Journal of Rare Diseases, 2010
- Congenital Factor VII Deficiency2010
- Factor VII DeficiencySeminars in Thrombosis and Hemostasis, 2009
- Major differences in bleeding symptoms between factor VII deficiency and hemophilia BJournal of Thrombosis and Haemostasis, 2009
- Congenital factor VII deficiency: therapy with recombinant activated factor VII – a critical appraisalHaemophilia, 2006
- Clinical phenotypes and factor VII genotype in congenital factor VII deficiencyThrombosis and Haemostasis, 2005
- Recessively inherited coagulation disordersBlood, 2004
- FACTOR VII DEFICIENCYBritish Journal of Haematology, 2002
- Use of Recombinant, Activated Factor VII in the Treatment of Congenital Factor VII DeficienciesVox Sanguinis, 1999